Are you and/or your team attending the DIA next month? Stop by our booth, D5, and talk to one of our team about how we can support you to optimise your path to approval.
We know that the path to drug approval is littered with pitfalls which can lead to unnecessary delays getting your medicine to the people who need it the most – the patients.
Working together we can:
- Accelerate your drug development program to reduce your time to approval
- Optimise the management of the regulatory process to provide accurate and predictable outcomes
- Reduce your risks and increase the probability of gaining Market Authorization
In addition to our team at the booth we have some great speakers sharing their knowledge in different forums throughout the conference, see below:
Brian Edwards – Principal Consultant
Tuesday, March 17th, 12:15-13:40, Regulatory Science Hub – Poster Presentation -#CHR 102: Skills, Communication and information in Pharmacovigilance – Oral Poster Presentations
Dr Mira Pavlovic – HTA Expert, NDA Regulatory Advisory Board member
Wednesday, March 18th, 12:00 – 13:15, Hall 300 – Session- #S0407: Drug Assessment for Regulatory and HTA Purposes: Similarities and Differences, the Way Forward
Prof. Beatriz Silva Lima – Non Clinical Expert, NDA Regulatory Advisory Board member
Wednesday, March 18th, 10:30 – 11:45, studio 214 +216 – Session – #DL04: Industry – Regulator Dialogue: Tailor-made Regulatory Guidance for Non-clinical to Clinical Development
Panelist: How has the New EU Guideline Changed the Conduct of First in Human Trials in Europe
Thursday, March 19th, 10:30 – 11:45 Panoramic Hall – Session- #S0512/0612: Panoramic Hall – Regulatory Science Training and Network in European Academia
Session Chair: Beatriz Silva Lima
RegSci Training actions in Portugal and beyond
Speaker: Beatriz Silva Lima.
Click here to download the Preliminary Programme.
Pre-book a meeting with one our team
To book a meeting contact firstname.lastname@example.org we look forward to seeing you at the in Brussels!